Jumei International Holding Limited (NYSE:JMEI)
Jumei International Holding Ltd. operates as an online retailer of beauty products. The Company’s product category includes cosmetics, skin care, cosmetics applicators, fragrance, body care, for men and for baby and children. It also offers women’s wear, footwear, lingerie, handbags and luggage, baby, children and maternity, menswear, sportswear and sporting goods, accessories, home goods and other lifestyle products, luxury goods and miscellaneous. The company sells its products through its Website Jumei.com, as well as through its mobile application. Jumei International Holding Limited is headquartered in Beijing, China.
Jumei International Holding Limited (NYSE:JMEI)’s Financial Overview
Jumei International Holding Limited (NYSE) declined -2.46% yesterday to close its trading session at $1.98. The company has 1 year Price Target of $12.5. Jumei International Holding Limited has 52-Week high of $3.73 and 52-Week Low of $1.44. The stock touched its 52-Week High on 4.03 and 52-Week Low on 1.44. The stock traded with the volume of 372936 shares yesterday. The firm shows the market capitalization of $305.69 Million.
The firm is trading with SMA20 of -2.44 Percent, SMA50 of -4.5 Percent and SMA200 of -11.43 percent. Jumei International Holding Limited has P/S value of 0.41 while its P/B value stands at 0.46. Similarly, the company has Return on Assets of 10.4 percent, Return on Equity of 13.2 percent and Return on Investment of -1.6 Percent. The company shows Gross Margin and Operating Margin of 23.1 percent and -2.8 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 1 analysts offering 12-month price forecasts for Jumei International Holding Ltd have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +607.07% increase from the last price of 1.98.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Flex Pharma, Inc. (NASDAQ:FLKS)
Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.
Flex Pharma, Inc. (NASDAQ:FLKS)’s Financial Outlook
The 1 analysts offering 12-month price forecasts for Flex Pharma Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +191.55% increase from the last price of 0.34.
Flex Pharma, Inc. is estimated to report earnings on 03/06/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.46.
According to Zacks Investment Research, Flex Pharma, Inc. has a Consensus Recommendation of 3. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined -2% and closed its last trading session at $0.34. The company has the market capitalization of $6.3 Million. The stock has 52-week high of $8.98 and 52-Week low of $0.26. The firm touched its 52-Week high on 8.98 and 52-Week low on 0.26. The company has volume of 1.3 Million shares. The company has a total of 18.37 Million shares outstanding.
Flex Pharma, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.5/share where the analyst estimated EPS was $-0.45/share. The difference between the actual and Estimated EPS is $-0.05. This shows a surprise factor of -11.1 percent.
The company has YTD performance of 3.97 percent. Beta for Flex Pharma, Inc. stands at 1.84 while its ATR (average true range) is 0.06. The company has Weekly Volatility of 14.88%% and Monthly Volatility of 14.77%%.
Flex Pharma, Inc. has distance from 20-day Simple Moving Average (SMA20) of -4.42%, Distance from 50-Day Simple Moving Average of -19.68 percent and Distance from 200-Day Simple Moving Average of -79.46%.
The Company currently has ROA (Return on Assets) of -121.3 percent, Return on Equity (ROE) of -148.1 Percent and Return on Investment (ROI) of -119.3% with Gross margin of 48.9 percent and Operating & Profit margin of 0% and 0% respectively.